KMKAX
Price
$77.04
Change
-$4.82 (-5.89%)
Updated
Dec 18 closing price
PMAQX
Price
$44.59
Change
-$1.66 (-3.59%)
Updated
Dec 18 closing price
Ad is loading...

KMKAX vs PMAQX

Header iconKMKAX vs PMAQX Comparison
Open Charts KMKAX vs PMAQXBanner chart's image
Kinetics Market Opportunities Adv A
Price$77.04
Change-$4.82 (-5.89%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$44.59
Change-$1.66 (-3.59%)
VolumeN/A
CapitalizationN/A
KMKAX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
KMKAX vs. PMAQX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMKAX is a Hold and PMAQX is a Hold.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.4B vs. KMKAX (241M). KMKAX pays higher dividends than PMAQX: KMKAX (0.58) vs PMAQX (0.10). KMKAX was incepted earlier than PMAQX: KMKAX (19 years) vs PMAQX (8 years). PMAQX is a more actively managed with annual turnover of: 10.10 vs. KMKAX (5.00). PMAQX has a lower initial minimum investment than KMKAX: PMAQX (0) vs KMKAX (2500). KMKAX annual gain was more profitable for investors over the last year : 99.45 vs. PMAQX (21.78). KMKAX return over 5 years is better than : 224.74 vs. PMAQX (50.76).
KMKAXPMAQXKMKAX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years8 years-
Gain YTD98.97920.631480%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets241M29.4B1%
Annual Yield % from dividends0.580.10581%
Returns for 1 year99.4521.78457%
Returns for 3 years112.3315.44728%
Returns for 5 years224.7450.76443%
Returns for 10 years405.40N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL253.482.44
+0.97%
Apple
PLSE19.240.07
+0.37%
Pulse Biosciences
TSLX20.690.04
+0.19%
Sixth Street Specialty Lending
KPTI0.67N/A
-0.51%
Karyopharm Therapeutics
SF107.18-2.28
-2.08%
Stifel Financial Corp